Stockreport

Contineum Therapeutics Highlights PIPE-791 IPF Trial, J&J-Backed PIPE-307 Catalysts at Leerink Conference [Yahoo! Finance]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF LPA1 inhibitor claimed to achieve ~ 90% receptor occupancy at ~1 mg QD with a 108-subject, 26-week Phase 2 IPF trial now enrolling, and PIPE-307 , a brain-penetrant M1 i [Read more]